BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2020
View Archived Issues
Mink stole show from bats in new COVID trouble
Read More
Cholesterol drug affects checkpoint blockade via MHC1
Read More
FDA accepts IND application for LY-3561774
Read More
2,4-Diamino-6-methylpyrimidines as novel histone lysine methyltransferase G9a/GLP inhibitors
Read More
Novel series of triaryl compounds acting as 20S proteasome inhibitors with subunit selectivity
Read More
Spectrum Antimicrobials developing SPC-069 for pulmonary infections
Read More
Topline phase III data reported for NurOwn in ALS
Read More
FDA issues complete response letter related to ALKS-3831 manufacturing records review
Read More
FDA clears IND for phase II/III study of RHB-107 in symptomatic COVID-19 disease
Read More
Vimpat CV approved in U.S. for PGTCS, pediatric use for Vimpat injection expanded
Read More
Alis Pharma patents fetal tissue extracts
Read More
New mutant EGFR inhibitors described by Bayer, The Broad Institute, Dana-Farber Cancer Institute
Read More
Mirati Therapeutics identifies new polycomb protein EED inhibitors
Read More
Rutgers describes new zinc complexes
Read More
Targeting ACPAs in rheumatoid arthritis
Read More
New bromodomain-containing protein inhibitors discovered by ConverGene, NIH
Read More
Results reported from first trial of NJH-395 in non-breast HER2-positive advanced malignancies
Read More
The unusual suspects: Test rapidly diagnoses any known pathogen from any available body fluid
Read More
First-in-human phase Ib data presented for CM-101 in patients with NAFLD
Read More
Early clinical data on SAR-441000 support further evaluation
Read More
EMA and Swissmedic begin rolling reviews of COVID-19 vaccine candidate mRNA-1273
Read More
FS-118 demonstrates early signs of clinical efficacy in PD-(L)1-resistant advanced cancer
Read More
IND cleared in U.S. for Vivet's phase I/II study of VTX-801 for Wilson's disease
Read More
FDA lifts clinical hold on phase I trial of UCARTCS1 for multiple myeloma
Read More
Phase I data pave way for phase II evaluation of PureTech's LYT-100
Read More
Avrobio announces pipeline update and new program in Gaucher disease type 3
Read More
New phase Ib study to evaluate motixafortide for ARDS
Read More
Final efficacy analysis shows phase III study of BNT-162b2 meets primary efficacy endpoints
Read More
